ClinicalTrials.Veeva

Menu

Screening for NAFLD in Flanders

H

Hasselt University

Status

Active, not recruiting

Conditions

Non-Alcoholic Fatty Liver Disease

Treatments

Other: screening

Study type

Interventional

Funder types

Other

Identifiers

NCT04647409
SCREEFLAN-01

Details and patient eligibility

About

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older,
  • able to understand Dutch,
  • able to understand the informed consent

Exclusion criteria

  • secondary causes of steatosis
  • excessive alcohol abuse

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10,000 participants in 1 patient group

participants
Other group
Treatment:
Other: screening

Trial contacts and locations

1

Loading...

Central trial contact

Geert Robaeys, prof. dr.; Leen Heyens, drs.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems